These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

849 related items for PubMed ID: 8840993

  • 1. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells.
    Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K.
    Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993
    [Abstract] [Full Text] [Related]

  • 2. Bcl-xL overexpression inhibits taxol-induced Yama protease activity and apoptosis.
    Ibrado AM, Huang Y, Fang G, Bhalla K.
    Cell Growth Differ; 1996 Aug 15; 7(8):1087-94. PubMed ID: 8853905
    [Abstract] [Full Text] [Related]

  • 3. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis.
    Fang G, Chang BS, Kim CN, Perkins C, Thompson CB, Bhalla KN.
    Cancer Res; 1998 Aug 01; 58(15):3202-8. PubMed ID: 9699642
    [Abstract] [Full Text] [Related]

  • 4. Bcl-xL overexpression inhibits progression of molecular events leading to paclitaxel-induced apoptosis of human acute myeloid leukemia HL-60 cells.
    Ibrado AM, Liu L, Bhalla K.
    Cancer Res; 1997 Mar 15; 57(6):1109-15. PubMed ID: 9067280
    [Abstract] [Full Text] [Related]

  • 5. Overexpression of bcl-2 or bcl-XL fails to inhibit apoptosis mediated by a novel retinoid.
    Fontana JA, Sun RJ, Rishi AK, Dawson MI, Ordónez JV, Zhang Y, Tschang SH, Bhalla K, Han Z, Wyche J, Poirer G, Sheikh MS, Shroot B, Reichert U.
    Oncol Res; 1998 Mar 15; 10(6):313-24. PubMed ID: 9848102
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of Bcl-X(L) inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
    Kim CN, Wang X, Huang Y, Ibrado AM, Liu L, Fang G, Bhalla K.
    Cancer Res; 1997 Aug 01; 57(15):3115-20. PubMed ID: 9242435
    [Abstract] [Full Text] [Related]

  • 7. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
    Ray S, Bullock G, Nuñez G, Tang C, Ibrado AM, Huang Y, Bhalla K.
    Cell Growth Differ; 1996 Dec 01; 7(12):1617-23. PubMed ID: 8959329
    [Abstract] [Full Text] [Related]

  • 8. Manganese induces apoptosis of human B cells: caspase-dependent cell death blocked by bcl-2.
    Schrantz N, Blanchard DA, Mitenne F, Auffredou MT, Vazquez A, Leca G.
    Cell Death Differ; 1999 May 01; 6(5):445-53. PubMed ID: 10381635
    [Abstract] [Full Text] [Related]

  • 9. Evidence against a direct role for the induction of c-jun expression in the mediation of drug-induced apoptosis in human acute leukemia cells.
    Bullock G, Ray S, Reed J, Miyashita T, Maria Ibrado A, Huang Y, Bhalla K.
    Clin Cancer Res; 1995 May 01; 1(5):559-64. PubMed ID: 9816016
    [Abstract] [Full Text] [Related]

  • 10. Involvement of CPP32/Caspase-3 in c-Myc-induced apoptosis.
    Kangas A, Nicholson DW, Hölttä E.
    Oncogene; 1998 Jan 22; 16(3):387-98. PubMed ID: 9467964
    [Abstract] [Full Text] [Related]

  • 11. Differential apoptosis-inducing effect of quercetin and its glycosides in human promyeloleukemic HL-60 cells by alternative activation of the caspase 3 cascade.
    Shen SC, Chen YC, Hsu FL, Lee WR.
    J Cell Biochem; 2003 Aug 01; 89(5):1044-55. PubMed ID: 12874837
    [Abstract] [Full Text] [Related]

  • 12. Bcl-2 prevents topoisomerase II inhibitor GL331-induced apoptosis is mediated by down-regulation of poly(ADP-ribose)polymerase activity.
    Kuo ML, Shen SC, Yang CH, Chuang SE, Cheng AL, Huang TS.
    Oncogene; 1998 Oct 29; 17(17):2225-34. PubMed ID: 9811453
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells.
    Perkins C, Kim CN, Fang G, Bhalla KN.
    Cancer Res; 1998 Oct 15; 58(20):4561-6. PubMed ID: 9788601
    [Abstract] [Full Text] [Related]

  • 14. The Bcl-xL and Bax-alpha control points: modulation of apoptosis induced by cancer chemotherapy and relation to TPCK-sensitive protease and caspase activation.
    Schmitt E, Sané AT, Steyaert A, Cimoli G, Bertrand R.
    Biochem Cell Biol; 1997 Oct 15; 75(4):301-14. PubMed ID: 9493953
    [Abstract] [Full Text] [Related]

  • 15. Acceleration of apoptotic cell death after the cleavage of Bcl-XL protein by caspase-3-like proteases.
    Fujita N, Nagahashi A, Nagashima K, Rokudai S, Tsuruo T.
    Oncogene; 1998 Sep 10; 17(10):1295-304. PubMed ID: 9771973
    [Abstract] [Full Text] [Related]

  • 16. Bcl-2 overexpression blocks activation of the death protease CPP32/Yama/apopain.
    Monney L, Otter I, Olivier R, Ravn U, Mirzasaleh H, Fellay I, Poirier GG, Borner C.
    Biochem Biophys Res Commun; 1996 Apr 16; 221(2):340-5. PubMed ID: 8619857
    [Abstract] [Full Text] [Related]

  • 17. Mechanism of UV-induced apoptosis in human leukemia cells: roles of Ca2+/Mg(2+)-dependent endonuclease, caspase-3, and stress-activated protein kinases.
    Kimura C, Zhao QL, Kondo T, Amatsu M, Fujiwara Y.
    Exp Cell Res; 1998 Mar 15; 239(2):411-22. PubMed ID: 9521859
    [Abstract] [Full Text] [Related]

  • 18. Toona sinensis extracts induces apoptosis via reactive oxygen species in human premyelocytic leukemia cells.
    Yang HL, Chang WH, Chia YC, Huang CJ, Lu FJ, Hsu HK, Hseu YC.
    Food Chem Toxicol; 2006 Dec 15; 44(12):1978-88. PubMed ID: 16945458
    [Abstract] [Full Text] [Related]

  • 19. Baculovirus P35 inhibits the glucocorticoid-mediated pathway of cell death.
    Robertson NM, Zangrilli J, Fernandes-Alnemri T, Friesen PD, Litwack G, Alnemri ES.
    Cancer Res; 1997 Jan 01; 57(1):43-7. PubMed ID: 8988038
    [Abstract] [Full Text] [Related]

  • 20. Apoptosis induced by vitamin D compounds in breast cancer cells is inhibited by Bcl-2 but does not involve known caspases or p53.
    Mathiasen IS, Lademann U, Jäättelä M.
    Cancer Res; 1999 Oct 01; 59(19):4848-56. PubMed ID: 10519395
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.